retatrutide parkinson clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss

In reality, up to 70% of patients stop GLP-1 treatment within a year most often due to: High cost (GLP-1s can cost $1,000+ per month without insurance) Loss of insurance coverage for weight loss treatment Side effects such as nausea, diarrhea, constipation, or fatigue A Misconceptions some patients stop once they lose initial weight, believing they no longer need the medication 2

Will people travel more because they are more active and spending less of their income and time eating at restaurants

Troy Watson at Set Point Weight Loss and Wellness Clinic in Roseville, CA, utilizes GLP-1 injections, such as Semaglutide GLP-1 and Tirzepatide , to aid in weight loss by reducing appetite and improving metabolic function

Regular follow-up is essential for all patients on GLP-1 therapy

So thanks so much, Dr

Additionally, further investigations are underway to explore potential additional uses of tirzepatide in the clinical management of other cardiometabolic conditions associated with obesity, including heart failure and non-alcoholic (or metabolic-dysfunction associated) steatohepatitis (NASH/MASH)